Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
Trends in Thyroid Cancer Incidence and Mortality in the United States, 1974-2013.
复制标题
DOI:
10.1001/jama.2017.2719
复制
发表时间:
2017-04-04
期刊:
影响因子:
--
通讯作者:
Kitahara CM
中科院分区:
文献类型:
--
作者:
Lim H;Devesa SS;Sosa JA;Check D;Kitahara CM
Thyroid cancer incidence has more than tripled in the United States over the last four decades, driven largely by increases in papillary thyroid cancer. It is unclear whether the rising incidence of papillary thyroid cancer has been related to thyroid cancer mortality trends. To compare trends in thyroid cancer incidence and mortality by tumor characteristics at diagnosis. Trends in thyroid cancer incidence and incidence-based mortality rates were evaluated using data from the Surveillance, Epidemiology, and End Results-9 cancer registry program. Tumor characteristics. Log-linear regression was used to calculate annual percent changes in age-adjusted thyroid cancer incidence and incidence-based mortality rates by histologic type and Surveillance, Epidemiology, and End Results stage for cases diagnosed during 1974–2013. Among 77,276 patients (mean age at diagnosis, 48 [standard deviation=16] years; 58,213 [75%] women) diagnosed with thyroid cancer from 1974–2013, papillary thyroid cancer was the most common histologic type (64,625 cases), and 2,371 deaths from thyroid cancer occurred during 1994–2013. Thyroid cancer incidence increased, on average, 3.6% per year (95% confidence interval 3.2–3.9%) during 1974–2013 (from 4.56 per 100,000 person-years in 1974–77 to 14.42 per 100,000 person-years in 2010–13), primarily driven by increases in papillary thyroid cancer (annual percent change=4.4%, 95% confidence interval 4.0–4.7%). Papillary thyroid cancer incidence increased for all stages at diagnosis (4.6% per year for localized, 4.3% per year for regional, 2.4% per year for distant, 1.8% per year for unknown). During 1994–2013, incidence-based mortality increased 1.1% per year (95% confidence interval 0.6–1.6%) (from 0.40 per 100,000 person-years in 1994–97 to 0.46 per 100,000 person-years in 2010–13) overall and 2.9% per year (95% confidence interval 1.1–4.7%) for distant papillary thyroid cancer. Among patients in the United States diagnosed with thyroid cancer from 1974–2013, the overall incidence of thyroid cancer increased 3% annually, with increases in the incidence rate and thyroid cancer mortality rate for advanced-stage papillary thyroid cancer. These findings are consistent with a true increase in the occurrence of thyroid cancer in the United States.
登录
查看更多内容
影响因子:
3.9
作者:
Mao Y;Xing M
通讯作者:
Xing M
影响因子:
168.9
作者:
Brose, Marcia S.;Nutting, Christopher M.;Jarzab, Barbara;Elisei, Rossella;Siena, Salvatore;Bastholt, Lars;de la Fouchardiere, Christelle;Pacini, Furio;Paschke, Ralf;Shong, Young Kee;Sherman, Steven I.;Smit, Johannes W. A.;Chung, John;Kappeler, Christian;Pena, Carol;Molnar, Istvan;Schlumberger, Martin J.
通讯作者:
Schlumberger, Martin J.
DOI:
10.1056/nejmoa0901249
发表时间:
2009-08-27
期刊:
The New England journal of medicine
影响因子:
--
作者:
Fazel R;Krumholz HM;Wang Y;Ross JS;Chen J;Ting HH;Shah ND;Nasir K;Einstein AJ;Nallamothu BK
通讯作者:
Nallamothu BK
影响因子:
7.2
作者:
CHU, KC;MILLER, BA;HANKEY, BF
通讯作者:
HANKEY, BF
影响因子:
2.3
作者:
Kitahara, Cari M.;Linet, Martha S.;Freeman, Laura E. Beane;Check, David P.;Church, Timothy R.;Park, Yikyung;Purdue, Mark P.;Schairer, Catherine;de Gonzalez, Amy Berrington
通讯作者:
de Gonzalez, Amy Berrington